Rapid Diagnosis of Multidrug-Resistant Organisms (MDROs) in Healthcare Settings: Advancements and Challenges
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 63
Special Issue Editor
Special Issue Information
Dear Colleagues,
Globally, antimicrobial resistance (AMR) is an urgent problem for health, with multidrug-resistant organisms (MDROs) being a major concern, especially in hospitals and long-term care facilities. People in these places are often more vulnerable and face greater risks. Thus, it is essential to quickly and accurately diagnose MDROs. A rapid diagnosis helps clinicians provide the right treatment and put strong infection control measures in place. Molecular technologies, such as PCR-based assays, have proven to be powerful tools for detecting MDROs at the genetic level, offering the advantage of faster identification compared to traditional microbiological methods, which can take several days.
This Special Issue of Microorganisms plans to collect recent research in relation to the advances and implementation of rapid diagnostic technologies in the field of AMR and MDRO detection. Original research articles and comprehensive reviews that cover the latest advancements in the rapid detection of MDROs, molecular surveillance, and epidemiology assessment by rapid diagnosis, as well as their implementation in sepsis diagnosis are welcomed.
Dr. Annapaola Callegaro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- multidrug-resistant organisms (MDROs)
- infection prevention and control (IPC)
- hospital-acquired infections (HAIs)
- molecular epidemiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
